Urgent Shareholder Alerts for Flywire and RxSight as Deadlines Near

New York, Tuesday, 2 September 2025.
Bernstein Liebhard LLP issues critical shareholder alerts for Flywire and RxSight, urging investors to act by late September 2025 to address potential legal implications and protect their investments.
Background on Flywire Corporation’s Legal Challenges
Flywire Corporation (NASDAQ: FLYW) is currently embroiled in a securities fraud class action lawsuit, which was initiated on behalf of investors who acquired the company’s securities between February 28, 2024, and February 25, 2025. The lawsuit alleges that Flywire made misleading statements about its revenue growth, which could have significant implications for investors [1]. Shareholders have until September 23, 2025, to file as lead plaintiffs in this lawsuit, a critical deadline that could influence their ability to seek legal recourse [1].
RxSight’s Alleged Misstatements and Legal Actions
Similarly, RxSight Inc. (NASDAQ: RXST) is facing a securities fraud class action lawsuit, with investors alleging that the company overstated product demand and failed to disclose structural challenges that affected its sales. This lawsuit covers securities purchases made between November 7, 2024, and July 8, 2025 [2]. Investors interested in joining the lawsuit must act by September 22, 2025, to ensure their claims are included, highlighting the urgency for stakeholders to stay informed and proactive [2].
Implications for Shareholders
These legal developments underscore the critical importance for shareholders of both Flywire and RxSight to remain vigilant. The approaching deadlines are not merely procedural; they represent pivotal moments that could determine the financial outcomes for investors involved in these class action lawsuits. Bernstein Liebhard LLP, the law firm managing both cases, has a long-standing reputation for recovering substantial sums for its clients, emphasizing the potential benefits of participating in these legal actions [1][2].
Conclusion: The Necessity of Proactive Investment Management
As the deadlines approach, shareholders of both Flywire and RxSight must consider their legal options carefully. Engaging with the class action suits could provide a path to financial recovery for those who believe they were misled by the companies’ statements. This situation exemplifies the necessity for investors to proactively manage their portfolios and remain informed about ongoing legal proceedings that could impact their investments significantly [1][2].